Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
D.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.64NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.327NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.396NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.129NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.221.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.224NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.6.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBJNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EJ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.31.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.77NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BY.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19772US
EG.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.424NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.89NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
M.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.333NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.429NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.463NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
U.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.373NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.80NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.433NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.574NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.355NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
GA.7.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.403NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used